NCT05883995招募中不适用
Avis-PHAGEinLYON Clinic
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,500
- 试验地点
- 1
- 主要终点
- Number of phage therapy requests
研究概览
简要总结
Avis-PHAGEinLYON Clinic study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients referred to the Hospices Civils de Lyon for a medical advice for a phage therapy from 2015 to 2028. The primary objective is to quantify the phage therapy requests received at the Hospices Civils de Lyon. 1500 patients will be included in the study.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/
- •Avis-PHAGEinLYON clinic study information notice provided to the patient
排除标准
- •- Opposition of trial participant
结局指标
主要结局
Number of phage therapy requests
时间窗: at inclusion
Number of phage therapy requests received at the Hospices Civils de Lyon from 2015 to 2028 per year and per month.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.Severe InfectionNCT06185920Hospices Civils de Lyon250
进行中（未招募）
4 期
A multi-hospital approach that depicts the routine practice of doctors treating patients with type 2 diabetes with Novomix 30, which will evaluate willingness and ability to pay in a real world population.CTRI/2017/10/010218ovo Nordisk India Private Ltd
Unknown
不适用
A Study to Prospectively Assess Disease Progression in Male Children With X-ALDX-Linked AdrenoleukodystrophyNCT03278899NeuroVia, Inc.100
Unknown
不适用
Retrospective Cohort Study on Post Analysis on the Link Between the Clinical Heart Rate and Outcomes During PCICoronary Heart DiseaseNCT02351674Dandan Li15,000
已完成
不适用
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment StudyUrothelial CarcinomaNCT06412848Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany360